Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Neurol Clin. 2022 Mar 31;40(2):437–453. doi: 10.1016/j.ncl.2021.11.003
Clinical Evaluation for patient presenting with neurological deficits or seizures:
  • Thorough history of presentation, symptoms, and physical examination

  • Computed tomography (CT) scan:

    Lesion that may be homo- or heterogenous with vasogenic edema.

  • MRI with and without gadolinium if suspected glioma on CT scan:

    Contrast enhancement, edema, gyral enlargement all strongly suggest high grade tumor.

    Lack of contrast enhancement in the setting of edema, gyral enlargement suggest low grade tumor.

  • Diffusion tensor imaging (DTI) allows for the visualization of tracts to assess tumor involvement in displacement of critical structures.

  • Functional MRI is helpful primarily for dominant hemisphere gliomas involving eloquent regions.

  • MR Spectroscopy can help delineate between glioma and other pathologies if the initial imaging and clinical presentation is not highly conclusive of glioma.

Initial Management
Symptom Management
  • Antiepileptics if there is any suspicion for prior epileptic activity.

  • In patients with new or worsening neurologic deficit, dexamethasone can improve clinical functioning by reducing vasogenic edema.

  • Any signs or symptoms of increased intracranial pressure or impending hydrocephalus should prompt urgent neurosurgical evaluation and consideration for inpatient admission.

  • Given the need for tissue diagnosis in most glioma patients, a thorough preoperative evaluation should be performed as well.